Royal Philips (PHG) and Masimo (MASI) announced that the two companies have renewed their multi-year strategic collaboration, marking a fresh chapter in their long-standing partnership. The two companies are taking a new approach in accelerating the development and delivery of next-generation patient monitoring solutions. “We are excited to continue to partner with Philips to bring Masimo’s newest innovations in wearables and artificial intelligence to Philips’ platforms,” said Katie Szyman, CEO of Masimo. “Expanding our strong, long-standing partnership with Philips allows us to build on our shared legacies of innovation and helps ensure that Masimo’s best-in-class technologies reach even more patients. Together, Masimo and Philips will continue to empower clinicians to transform patient care.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHG:
- Masimo, Philips announce multi-year renewal and expansion of partnership
- Philips launches smart telemetry platform for cardiac monitoring
- Philips launches Transcend Plus for EPIQ CVx, Affiniti CVx
- Philips announces plans for more than $150M manufacturing investment in U.S.
- Philips added to European Conviction List at Goldman Sachs